Company Filing History:
Years Active: 2012
Title: Akira Okimoto: Innovator in Heterocyclic Janus Kinase 3 Inhibitors
Introduction
Akira Okimoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of innovative compounds for treating diseases.
Latest Patents
Okimoto holds a patent for Heterocyclic Janus Kinase 3 inhibitors. This invention relates to a compound of the formula (I) or its salt, wherein —R, —R, —R, —R, —R, -M-, —X— and —Y— are as defined in the description. The patent outlines their use as a medicament, the process for their preparation, and their application in the treatment of JAK3 mediated diseases. He has 1 patent to his name.
Career Highlights
Okimoto is currently employed at Astellas Pharma GmbH, where he continues to advance his research and development efforts. His work focuses on creating effective treatments for various medical conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Throughout his career, Okimoto has collaborated with notable colleagues, including Takayuki Inoue and Takashi Tojo. These partnerships have fostered a collaborative environment that enhances innovation and research.
Conclusion
Akira Okimoto's contributions to the field of medicinal chemistry, particularly through his patent on Heterocyclic Janus Kinase 3 inhibitors, highlight his role as a key innovator in the industry. His work at Astellas Pharma GmbH and collaborations with esteemed colleagues further emphasize his commitment to advancing medical science.